Ascletis prices Hong Kong IPO at $400M

Antiviral company Ascletis Pharma Inc. (HKSE:1672) priced its IPO on Hong

Read the full 110 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE